COMPANY

Remedium Bio

Keywords: immunology metabolic musculoskeletal obesity type 2 diabetes mellitus gene therapy

Location: Boston, MA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $1.5M (Form D filed May 18, 2026). SEC Form D 0001892414-26-000004 (May 18, 2026)
Evidence (1 event)
- May 18, 2026 · SEC Form D 0001892414-26-000004
  Name of Issuer: Remedium Bio Inc.; CIK: 1892414; Address: Needham, MA; Submission type: D; Filing date: 2026-05-18; Industry Group: Biotechnology; Date of First Sale: 2026-05-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 10000000; Total Amount Sold: 1500000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals